SABCS 2022 Conference Coverage


 

SABCS 2022 TROPiCS-02 Phase 3 Study of Patients With HR+/HER2- mBC: Sacituzumab Govitecan vs. Treatment of Physician’s Choice - Efficacy by Trop-2 Expression

172 views
December 23, 2022
Comments 0
Login to view comments. Click here to Login